Back to Research Home
UTMDUtah Medical Products Inc
Health Care · Medical/Dental Instruments · Micro
$74.23−1.11%
As of 23 Oct 2026Mkt cap $228M
Stage 13
WATCH
Fundamentals
44.8/75
Technical
6.1/15
Independent
50.9/90
GCAE viewbusiness is credible but technical recovery is not yet actionable
Price
- 1M
- −0.7%
- 3M
- +7.4%
- 6M
- +10.5%
- 1Y
- +21.6%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 22.6xHist median 15.5x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 21.0x
- FCF yield
- 4.8%
Quality
- ROIC
- 26.6%
- Operating margin
- 33.2%
- FCF margin
- 37.2%
- Current ratio
- 37.6x
Growth
- Revenue growth
- −5.8%Latest FY YoY
- Revenue CAGR
- −5.9%
- EPS CAGR
- −3.7%
- FCF CAGR
- −8.7%
Capital
- Share-count trend
- −5.6%3Y annualised
- Net cash
- $86M-5.8x OCF
Annual trend
- CAGR 2021–2025
- −5.9%
- Latest · 2025
- $0B
- YoY
- −5.8%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
business is credible but technical recovery is not yet actionable
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-01-28
More details & evidence
Production decision
- Stage 13
- WATCH
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded